Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Höfner

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Medicinal Chemistry|June 29, 2014
Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamidesPaula Kowalczyk, Kinga Sałat, Georg C Höfner, et al.
Pharmacological Reports : PR|October 23, 2012
Synthesis and pharmacological properties of new GABA uptake inhibitorsKinga Sałat, Anna Więckowska, Krzysztof Więckowski, et al.
Analytica Chimica Acta|October 23, 2016
Development, validation and application of a 96-well enzymatic assay based on LC-ESI-MS/MS quantification for the screening of selective inhibitors against Mycobacterium tuberculosis purine nucleoside phosphorylaseGiulia Cattaneo, Daniela Ubiali, Enrica Calleri, et al.
ACS Chemical Neuroscience|August 4, 2021
Novel Functionalized Amino Acids as Inhibitors of GABA Transporters with Analgesic ActivityBeata Gryzło, Paula Zaręba, Katarzyna Malawska, et al.
European Journal of Medicinal Chemistry|January 6, 2020
Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in micePaula Zaręba, Beata Gryzło, Katarzyna Malawska, et al.
European Journal of Medicinal Chemistry|May 20, 2021
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activityPaula Zaręba, Kinga Sałat, Georg C Höfner, et al.
European Journal of Medicinal Chemistry|October 14, 2023
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's diseasePaula Zaręba, Kamil Łątka, Gabriela Mazur, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Medicinal Chemistry|June 29, 2014
Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamidesPaula Kowalczyk, Kinga Sałat, Georg C Höfner, et al.
Pharmacological Reports : PR|October 23, 2012
Synthesis and pharmacological properties of new GABA uptake inhibitorsKinga Sałat, Anna Więckowska, Krzysztof Więckowski, et al.
Analytica Chimica Acta|October 23, 2016
Development, validation and application of a 96-well enzymatic assay based on LC-ESI-MS/MS quantification for the screening of selective inhibitors against Mycobacterium tuberculosis purine nucleoside phosphorylaseGiulia Cattaneo, Daniela Ubiali, Enrica Calleri, et al.
ACS Chemical Neuroscience|August 4, 2021
Novel Functionalized Amino Acids as Inhibitors of GABA Transporters with Analgesic ActivityBeata Gryzło, Paula Zaręba, Katarzyna Malawska, et al.
European Journal of Medicinal Chemistry|January 6, 2020
Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in micePaula Zaręba, Beata Gryzło, Katarzyna Malawska, et al.
European Journal of Medicinal Chemistry|May 20, 2021
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activityPaula Zaręba, Kinga Sałat, Georg C Höfner, et al.
European Journal of Medicinal Chemistry|October 14, 2023
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's diseasePaula Zaręba, Kamil Łątka, Gabriela Mazur, et al.
Pageof 2